Oak Asset Management’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $250K | Hold |
3,199
| – | – | 0.09% | 95 |
|
2025
Q1 | $232K | Sell |
3,199
-500
| -14% | -$36.2K | 0.09% | 96 |
|
2024
Q4 | $274K | Hold |
3,699
| – | – | 0.1% | 92 |
|
2024
Q3 | $244K | Hold |
3,699
| – | – | 0.09% | 96 |
|
2024
Q2 | $342K | Hold |
3,699
| – | – | 0.13% | 83 |
|
2024
Q1 | $353K | Sell |
3,699
-512
| -12% | -$48.9K | 0.13% | 83 |
|
2023
Q4 | $321K | Hold |
4,211
| – | – | 0.13% | 86 |
|
2023
Q3 | $292K | Hold |
4,211
| – | – | 0.13% | 87 |
|
2023
Q2 | $397K | Hold |
4,211
| – | – | 0.16% | 78 |
|
2023
Q1 | $348K | Sell |
4,211
-12
| -0.3% | -$993 | 0.15% | 80 |
|
2022
Q4 | $315K | Hold |
4,223
| – | – | 0.14% | 82 |
|
2022
Q3 | $349K | Buy |
+4,223
| New | +$349K | 0.17% | 80 |
|
2022
Q2 | – | Sell |
-4,423
| Closed | -$521K | – | 101 |
|
2022
Q1 | $521K | Hold |
4,423
| – | – | 0.21% | 72 |
|
2021
Q4 | $573K | Sell |
4,423
-200
| -4% | -$25.9K | 0.22% | 72 |
|
2021
Q3 | $514K | Hold |
4,623
| – | – | 0.21% | 73 |
|
2021
Q2 | $479K | Buy |
+4,623
| New | +$479K | 0.2% | 74 |
|
2021
Q1 | – | Sell |
-4,623
| Closed | -$422K | – | 63 |
|
2020
Q4 | $422K | Sell |
4,623
-192
| -4% | -$17.5K | 0.21% | 75 |
|
2020
Q3 | $382K | Buy |
4,815
+12
| +0.2% | +$952 | 0.2% | 74 |
|
2020
Q2 | $332K | Hold |
4,803
| – | – | 0.2% | 75 |
|
2020
Q1 | $302K | Sell |
4,803
-150
| -3% | -$9.43K | 0.22% | 72 |
|
2019
Q4 | $385K | Hold |
4,953
| – | – | 0.21% | 72 |
|
2019
Q3 | $363K | Hold |
4,953
| – | – | 0.22% | 73 |
|
2019
Q2 | $320K | Hold |
4,953
| – | – | 0.2% | 78 |
|
2019
Q1 | $316K | Hold |
4,953
| – | – | 0.21% | 70 |
|
2018
Q4 | $253K | Hold |
4,953
| – | – | 0.19% | 74 |
|
2018
Q3 | $287K | Hold |
4,953
| – | – | 0.17% | 83 |
|
2018
Q2 | $240K | Hold |
4,953
| – | – | 0.16% | 86 |
|
2018
Q1 | $230K | Buy |
+4,953
| New | +$230K | 0.18% | 84 |
|